Go Pro
OTCMKTS:CNTMF

Cansortium Full Year Earnings Report

Cansortium logo
$0.02 0.00 (-4.17%)
As of 09/25/2026 03:44 PM Eastern

Cansortium EPS Results

Actual EPS
-$0.16
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
-$0.14

Cansortium Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cansortium Announcement Details

Quarter
Full Year
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Cansortium Earnings Headlines

FLUENT Reports Second Quarter 2026 Results
Fluent Corp.
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. One day it's a ceasefire, the next it's bombs again. The back and forth may be masking a bigger story most investors are missing. See the real reason this conflict may never fully end.tc pixel
See More Cansortium Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cansortium? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cansortium and other key companies, straight to your email.

About Cansortium

Cansortium (OTCMKTS:CNTMF) is a vertically integrated cannabis company that cultivates, processes, manufactures and sells medical and adult-use cannabis products. The company markets its products primarily under the Fluent brand, with offerings that may include flower, pre-rolls, vape products, concentrates, edibles and other cannabis-derived products, depending on local regulations.

Cansortium operates through a combination of cultivation and processing facilities, retail dispensaries and wholesale distribution activities. Its business is focused on state-regulated cannabis markets in the United States, with operations and retail presence historically centered in Florida and expanded into additional markets, including Pennsylvania and Michigan.

The company has developed its operations as a seed-to-sale platform, allowing it to manage multiple stages of production and distribution. Cansortium serves registered medical cannabis patients and, where permitted, adult-use consumers through its retail network and state-compliant product channels.

View Cansortium Profile